Nolato AB (NOLA B):企業の財務・戦略的SWOT分析

◆英語タイトル:Nolato AB (NOLA B) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1582
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Nolato AB (NOLA B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nolato AB (Nolato) manufactures and markets polymer products and components. The company offers products such as breathing bags, catheter balloons, EMI shielding, thermal management, laboratory products, pharma packaging and protection plugs. It provides mobile phone components including display windows, complete front and back sections, and other specialist components. Nolato offers primary plastic packaging for pharmaceuticals and life-enhancing vitamin and mineral supplements. The company caters to medical technology, pharmaceuticals, telecom, automotive and other sectors. It operates in the UK, Hungary, France, China, India, Malaysia, the Czech Republic, Romania, Germany and others. Nolato is headquartered in Torekov, Sweden.

Nolato AB Key Recent Developments

Feb 10,2020 Nolato Q4 2019: Good performance by all business areas
Oct 23,2019 Nolato Q3 2019: Positive earnings performance by all business areas
May 08,2019 Nolato Q1 2019: Continued strong performance from medical solutions
Feb 12,2019 Nolato year-end report: Strong financial position and proposed increase in dividend

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Nolato AB – Key Facts
Nolato AB – Key Employees
Nolato AB – Key Employee Biographies
Nolato AB – Major Products and Services
Nolato AB – History
Nolato AB – Company Statement
Nolato AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Nolato AB – Business Description
Business Segment: Industrial Solutions
Overview
Performance
Business Segment: Integrated Solutions
Overview
Performance
Business Segment: Medical Solutions
Overview
Performance
Geographical Segment: Asia
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other Nordic Countries
Performance
Geographical Segment: Rest of Europe
Performance
Geographical Segment: Sweden
Performance
Nolato AB – SWOT Analysis
SWOT Analysis – Overview
Nolato AB – Strengths
Nolato AB – Weaknesses
Nolato AB – Opportunities
Nolato AB – Threats
Nolato AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Feb 10, 2020: Nolato Q4 2019: Good performance by all business areas
Oct 23, 2019: Nolato Q3 2019: Positive earnings performance by all business areas
May 08, 2019: Nolato Q1 2019: Continued strong performance from medical solutions
Feb 12, 2019: Nolato year-end report: Strong financial position and proposed increase in dividend
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Nolato AB, Key Facts
Nolato AB, Key Employees
Nolato AB, Key Employee Biographies
Nolato AB, Major Products and Services
Nolato AB, History
Nolato AB, Subsidiaries
Nolato AB, Key Competitors
Nolato AB, Ratios based on current share price
Nolato AB, Annual Ratios
Nolato AB, Annual Ratios (Cont...1)
Nolato AB, Annual Ratios (Cont...2)
Nolato AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Nolato AB, Performance Chart (2015 - 2019)
Nolato AB, Ratio Charts

★海外企業調査レポート[Nolato AB (NOLA B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Optus Inc:企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Memphasys Ltd (MEM)-製薬・医療分野:企業M&A・提携分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a life science company that develops and sells pre-cast electrophoresis gels, separations equipment and consumables, analytical software, and other biological products. The company offers gels which include tris glycine, and tris hepe …
  • Apollo Education Group, Inc.:企業の戦略・SWOT・財務分析
    Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SKYCITY Entertainment Group Ltd:戦略・SWOT・企業財務分析
    SKYCITY Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary SKYCITY Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Zayo Group Holdings Inc (ZAYO):企業の財務・戦略的SWOT分析
    Zayo Group Holdings Inc (ZAYO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Telia Company (TELIA):企業の財務・戦略的SWOT分析
    Telia Company (TELIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Postnl N.V.:企業の戦略・SWOT・財務分析
    Postnl N.V. - Strategy, SWOT and Corporate Finance Report Summary Postnl N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Israel Institute of Technology:製薬・医療:M&Aディール及び事業提携情報
    Summary Israel Institute of Technology (Technion) is a research university that offers science and technology programs. The university offers various undergraduate and graduate programs in biology, biomedical engineering, biotechnology and food engineering, chemical engineering, and medicine and env …
  • Allscripts Healthcare Solutions Inc (MDRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Allscripts Healthcare Solutions Inc (Allscripts), formerly Allscripts-Misys Healthcare Solutions, Inc., is a provider of healthcare information technology solutions. The company’s major solutions include Electronic Health Records (EHR), Financial Management Solutions, Population Health Manag …
  • Cellectar Biosciences Inc (CLRB):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellectar Biosciences Inc (Cellectar) develops phospholipid drug conjugates (PDCs) for the treatment and diagnosis of cancer. Its lead product, CLR 131, is a small-molecule radiotherapeutic PDC, being developed for the treatment of relapse or refractory multiple myeloma. Cellectar’s other pr …
  • FluGen Inc-製薬・医療分野:企業M&A・提携分析
    Summary FluGen Inc (FluGen) is a healthcare services provider that offers vaccine and therapies. The company discovers, develops and commercializes new methods for the prevention and treatment of influenza infections. Its product includes redeeflu that contains mutations in the M2 gene of the virus. …
  • InTouch Technologies Inc:企業の戦略的SWOT分析
    InTouch Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Cytodyn Inc (CYDY):企業の財務・戦略的SWOT分析
    Summary Cytodyn Inc (Cytodyn) is a clinical-stage biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment of Human Immunodeficiency Virus (HIV) infections. Its pipeline products include Leronlimab (PRO 140), a ful …
  • Best Buy Co, Inc.:企業のM&A・事業提携・投資動向
    Best Buy Co, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Best Buy Co, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Gulf Power Co:電力:M&Aディール及び事業提携情報
    Summary Gulf Power Co (Gulf Power), a subsidiary of Southern Company, is an integrated energy utility. It generates, procures, transmits, and distributes electricity. The company produces electricity using coal and gas sources. Through agreements with industrial, commercial, and qualifying facilitie …
  • Oki Electric Industry Co., Ltd. (6703):企業の財務・戦略的SWOT分析
    Oki Electric Industry Co., Ltd. (6703) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • SMS Pharmaceuticals Ltd (SMSPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary SMS Pharmaceuticals Ltd (SMS Pharma) is a manufacturer of active pharmaceutical ingredients (APIs) and intermediates that develops offers anti-fungal, anti-ulcer, anti-migraine, anti-hypersensitive, anti-psychotic, anti-viral and other products. Its pipeline products include Ticagrelor, Clop …
  • Nuffield Health:企業の戦略的SWOT分析
    Nuffield Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Detour Gold Corp:企業の戦略・SWOT・財務情報
    Detour Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Detour Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Portola Pharmaceuticals Inc (PTLA):製薬・医療:M&Aディール及び事業提携情報
    Summary Portola Pharmaceuticals Inc (Portola Pharmaceuticals) is a biopharmaceutical company which conducts research to develop therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. The company's products portfolio include Betrixaban, an oral once-daily Factor Xa inh …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆